Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Andlauer Healthcare Gr

Industrials CA AND

54.97CAD
-(-%)

Last update at 2025-11-05T14:30:00Z

Day Range

54.9754.97
LowHigh

52 Week Range

36.4054.81
LowHigh

Fundamentals

  • Previous Close 54.97
  • Market Cap2135.64M
  • Volume0
  • P/E Ratio32.09
  • Dividend Yield0.84%
  • EBITDA104.26M
  • Revenue TTM650.58M
  • Revenue Per Share TTM16.57
  • Gross Profit TTM 220.20M
  • Diluted EPS TTM1.70

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 103.76M 108.44M 46.58M 42.35M 38.72M
Minority interest - - 0.00000M -0.57200M 5.92M
Net income 76.28M 89.95M 37.71M 29.77M 26.72M
Selling general administrative 48.50M 37.05M 28.61M 23.09M 21.68M
Selling and marketing expenses - - - - -
Gross profit 158.85M 110.75M 79.55M 68.08M 62.55M
Reconciled depreciation 64.45M 42.72M 28.02M 25.71M 23.49M
Ebit 110.34M 73.70M 50.94M 44.99M 40.30M
Ebitda 175.07M 119.45M 79.20M 71.56M 63.79M
Depreciation and amortization 64.72M 45.75M 28.26M 26.57M 23.49M
Non operating income net other - - - - -
Operating income 110.34M 73.70M 50.94M 44.99M 40.87M
Other operating expenses 538.08M 366.41M 263.40M 245.00M 236.14M
Interest expense 6.86M 6.22M 4.59M 3.50M 3.05M
Tax provision 27.48M 18.49M 8.87M 12.00M 10.53M
Interest income 6.26M 34.37M 4.31M 2.50M 2.17M
Net interest income -6.25900M -6.02100M -4.31000M -2.49900M -2.16900M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 27.48M 18.49M 8.87M 12.00M 10.53M
Total revenue 648.42M 440.12M 314.34M 289.99M 277.01M
Total operating expenses 48.50M 37.05M 28.61M 23.09M 21.68M
Cost of revenue 489.58M 329.36M 234.79M 221.90M 214.46M
Total other income expense net -6.58700M 34.74M -4.35900M -2.64400M -2.15000M
Discontinued operations - - - - -
Net income from continuing ops 76.28M 89.95M 37.71M 30.34M 28.18M
Net income applicable to common shares 76.28M 89.95M 37.71M 29.77M 26.72M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 696.92M 682.43M 712.46M 644.17M 252.80M
Intangible assets 134.52M 144.36M 164.79M 158.46M 8.61M
Earning assets - - - - -
Other current assets 6.37M 6.61M 4.42M 4.66M 2.83M
Total liab 265.78M 212.86M 271.47M 292.05M 158.47M
Total stockholder equity 431.13M 469.57M 440.99M 352.12M 94.33M
Deferred long term liab - - - - -
Other current liab - 0.45M 16.31M 13.68M 3.03M
Common stock - 718.79M 727.84M 719.94M 549.66M
Capital stock 673.87M 718.79M 727.84M 719.94M 549.66M
Retained earnings 205.38M -269.72200M 176.62M 111.23M 29.13M
Other liab - - 48.95M 51.72M 1.98M
Good will 199.15M 190.56M 192.91M 176.74M 25.87M
Other assets - - 5.81M 8.68M 6.95M
Cash 40.48M 59.74M 65.86M 24.99M 30.15M
Cash and equivalents - - 65.86M 24.99M 30.15M
Total current liabilities 106.23M 69.49M 85.78M 90.53M 48.08M
Current deferred revenue - 0.97M 1.14M 1.82M 1.04M
Net debt 14.41M 68.16M 97.43M 162.26M 99.47M
Short term debt - 27.70M 26.55M 37.45M 21.20M
Short long term debt 30.00M - - 11.00M -
Short long term debt total - 127.90M 163.29M 187.25M 129.61M
Other stockholder equity - 6.31M 5.81M 4.97M 4.45M
Property plant equipment - - 175.88M 178.11M 118.92M
Total current assets 168.93M 175.11M 172.08M 122.18M 92.45M
Long term investments - - - - -
Net tangible assets - - 83.29M 16.92M 59.85M
Short term investments - - - - -
Net receivables 110.45M 103.44M 98.48M 90.20M 58.25M
Long term debt 24.89M 24.82M 49.56M 49.29M 24.67M
Inventory 8.93M 5.33M 3.33M 2.33M 1.23M
Accounts payable 43.35M 40.38M 41.78M 37.59M 24.32M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 14.19M -469.27400M -484.01700M -488.91600M
Additional paid in capital - - - - -
Common stock total equity - - - - 549.66M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 1.29M 0.91M 1.00M 0.85M 0.81M
Deferred long term asset charges - - - - -
Non current assets total 527.99M 507.31M 540.38M 521.99M 160.34M
Capital lease obligations 126.31M 103.08M 113.73M 126.96M 104.95M
Long term debt total - - 136.74M 149.81M 108.42M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -45.55700M -7.64800M -20.37100M -6.16500M -2.49700M
Change to liabilities 1.49M 4.45M -0.94800M -2.15400M 4.13M
Total cashflows from investing activities -45.55700M -183.38200M -20.37100M -6.16500M -2.49700M
Net borrowings -40.03400M 10.89M -24.66500M -176.35700M -16.81700M
Total cash from financing activities -51.58700M 93.89M -19.19600M -89.78100M -46.33200M
Change to operating activities 0.33M -0.12100M -0.26900M -1.07900M 0.17M
Net income 76.28M 89.95M 37.71M 30.34M 28.18M
Change in cash 40.87M -5.15800M 11.44M -34.94500M 3.51M
Begin period cash flow 24.99M 30.15M 18.71M 53.66M 50.15M
End period cash flow 65.86M 24.99M 30.15M 18.71M 53.66M
Total cash from operating activities 137.13M 84.09M 51.00M 61.00M 52.34M
Issuance of capital stock 0.00000M 97.05M 0.00000M 172.50M -
Depreciation 64.45M 42.72M 28.02M 25.71M 23.49M
Other cashflows from investing activities -17.59700M -173.71400M -14.93200M 0.00000M 0.09M
Dividends paid 10.88M 7.85M 7.93M 112.02M 26.00M
Change to inventory -0.31700M -0.47200M -0.15700M 0.29M -0.20400M
Change to account receivables -2.85500M -14.18400M -3.04000M -2.63000M -3.44700M
Sale purchase of stock 0.00000M 97.05M 0.00000M 50.00M -
Other cashflows from financing activities 11.33M 68.80M 13.40M 76.09M -3.51500M
Change to netincome -0.79200M -42.56900M -3.13800M 2.44M 1.46M
Capital expenditures 27.96M 9.67M 5.44M 6.17M 2.59M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -3.07600M -6.25200M -11.59500M 3.09M 0.66M
Stock based compensation 1.30M 1.86M 3.04M 1.39M -
Other non cash items 0.22M -40.39300M 0.10M 0.21M 0.00100M
Free cash flow 109.17M 74.42M 45.56M 54.84M 49.75M

Peer Comparison

Sector: Industrials Industry: Integrated Freight & Logistics

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AND
Andlauer Healthcare Gr		 - -% 54.97 32.09 27.10 3.28 4.66 3.33 12.81
UPS
UPS CDR (CAD Hedged)		 0.12 0.94% 12.84 - - - -
CJT
Cargojet Inc		 0.27 0.31% 88.49 11.96 22.57 1.42 1.97 2.30 5.86
TTNM
Titanium Transportation Group Inc.		 0.01 0.45% 2.21 - 25.91 0.22 1.28 0.49 13.51

Reports Covered

Stock Research & News

View All

Profile

Andlauer Healthcare Group Inc., a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics. It provides logistics and distribution services, including client and customer integration, transportation and inventory management, distribution and fulfillment, and warehousing solutions; and packaging services, such as co-packing and re-packing, assembly, and custom work services, as well as design, supply, and secondary Rx packaging services. The company also offers temperature-controlled services; air freight forwarding services; dedicated and last mile delivery services; and ground transportation services, including less-than-truckload, pick-up and delivery, and courier services, as well as carrier options. It serves healthcare manufacturers, wholesalers, distributors, 3PL providers, and others through a platform of technology-enabled supply chain solutions for a range of products, including pharmaceuticals, vaccines, biologics, blood products, narcotics, precursors, active pharmaceutical ingredients, over-the-counter, cosmetics, health and beauty aids, and medical devices, as well as natural, animal, and consumer health. The company was founded in 1991 and is headquartered in Vaughan, Canada. Andlauer Healthcare Group Inc. operates as a subsidiary of Andlauer Management Group Inc.

Andlauer Healthcare Gr

100 Vaughan Valley Boulevard, Vaughan, ON, Canada, L4H 3C5

Key Executives

Name Title Year Born
Mr. Michael N. Andlauer CEO & Director 1965
Mr. Peter Bromley C.A., CPA CFO & Corp. Sec. 1964
Mr. Charles Robert Brogan Pres of Specialty Solutions 1961
Mr. Stephen Barr Pres of Transportation 1965
Mr. Dean Berg Pres of Logistics NA
Mr. Peter Bromley C.A., CPA CFO & Corporate Secretary 1964
Mr. Charles Robert Brogan President of Specialty Solutions 1961
Mr. Dean Berg President of Logistics NA
Mr. Graham Cromb Chief Strategy Officer NA
Mr. Sandro Caccaro President of Transportation NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.